Episcleral plaque brachytherapy for retinoblastoma
Authors:
- Thomas E. MerchantTMThomas E. Merchant
- Ciara J. GouldCGCiara J. Gould
- 24 May 2004
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 43 (2) , 134-139
Abstract
Background: The purpose of this study was to report our experience using episcleral plaque brachytherapy (EPBRT) to treat retinoblastoma and to demonstrate its applicability in multimodality treatment.Procedure: We treated 26 tumors in 25 eyes from a group of 21 children with unilateral (n = 4) or bilateral (n = 17) retinoblastoma. The group comprised 8 girls and 13 boys; the median age was 25 months (range: 2–64 months) at the time of EPBRT. Iodine‐125 (125I) was used for all applications. The median dose was 44 Gy (range: 35–47.6 Gy). EPBRT was administered primarily at the time of relapse after primary chemotherapy or radiation therapy.Results: For eyes treated with EPBRT, the eye preservation rate was 15/25 with a median follow‐up of 47 months (range: 2–198 months); the lesion control rate was 25/26 with a median follow‐up of 13 months (range: 1–140 months). The median time to additional whole‐eye treatment after EPBRT was 12 months (range: 2–105 months).Conclusions: Similar to previously reported series, EPBRT shows a high rate of successful tumor control as a primary treatment for retinoblastoma, as well as a secondary therapy at the time of relapse. EPBRT also allows for a clinically significant delay in the time to additional measures for the affected eye. Therefore, EPBRT should be considered as a form of local ophthalmic therapy that avoids or delays the use of external‐beam radiotherapy, especially for patients primarily treated with chemotherapy who might require consolidation therapy.Keywords
This publication has 14 references indexed in Scilit:
- Screening for Retinoblastoma: Presenting Signs as Prognosticators of Patient and Ocular SurvivalPediatrics, 2003
- Plaque radiotherapy for retinoblastoma Long-term tumor control and treatment complications in 208 tumorsOphthalmology, 2001
- Localized whole eye radiotherapy for retinoblastoma using a 125 I applicator, “claws”International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Distribution of tumors in the retina in hereditary retinoblastoma patientsOphthalmic Genetics, 1998
- Brachytherapy in primary ocular tumorsSeminars in Surgical Oncology, 1997
- RETINOBLASTOMA RECURRENCE AFTER IODINE 125 PLAQUE APPLICATIONRetina, 1996
- Regression of Retinoblastoma After Plaque RadiotherapyAmerican Journal of Ophthalmology, 1993
- Plaque Radiotherapy in the Management of RetinoblastomaOphthalmology, 1993
- Episcleral Plaque Radiotherapy for RetinoblastomaOphthalmology, 1989
- The use of iodine-125 plaques in the treatment of retinoblastomaOphthalmic Paediatrics and Genetics, 1987